ArticleOncotarget2016
Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Yingzi Qi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it